drugset / Trial / NCT03638830
Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
Phase 2
Completed
777 enrolled
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Acellena Contract Drug Research and Development · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is planned to evaluate the safety and efficacy of the drug Ftortiazinon in combination with the drug Maxipime® in comparison with placebo in combination with the drug Maxipime® in the treatment of hospitalized adult patients with complicated urinary tract infections caused by P. aeruginosa.
Timeline
- Start
- 2018-10-17
- Primary completion
- 2022-11-23
- Completion
- 2022-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ftortiazinon | Unknown | 300 mg | Oral |
| Background | Cefepime | Small molecule | 1 g | Intravenous |